{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T10:00:04Z","timestamp":1794391204068,"version":"4.9.0"},"publisher-location":"Boston, MA","reference-count":36,"publisher":"Springer US","isbn-type":[{"value":"9781461358015","type":"print"},{"value":"9781461519515","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1995]]},"DOI":"10.1007\/978-1-4615-1951-5_29","type":"book-chapter","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T11:51:32Z","timestamp":1310989892000},"page":"209-218","source":"Crossref","is-referenced-by-count":11,"title":["Neuroendocrine Effects of Interferon-\u03b1 in the Rat"],"prefix":"10.1007","author":[{"given":"David","family":"Saphier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1146\/annurev.bi.56.070187.003455","volume":"56","author":"S Pestka","year":"1987","unstructured":"S. Pestka, J. A. Langer, K. C. Zoon, and C. E. Samuel. Interferons and their actions. Ann. Rev. Biochem. 56:727 (1987).","journal-title":"Ann. Rev. Biochem."},{"key":"29_CR2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/0168-8278(90)90156-L","volume":"11","author":"F Dianzani","year":"1990","unstructured":"F. Dianzani, G. Antonelli, and M. R. Capobianchi, The biological basis for clinical use of interferon. J. Hepatol. 11:S5 (1990).","journal-title":"J. Hepatol."},{"key":"29_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0065-2776(08)60378-8","volume":"341","author":"RM Friedman","year":"1983","unstructured":"R. M. Friedman, and S. N. Vogel. Interferon with special emphasis on the immune system. Adv. Immunol. 341:97 (1983).","journal-title":"Adv. Immunol."},{"key":"29_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1089\/jir.1990.10.599","volume":"10","author":"D Fuchs","year":"1990","unstructured":"D. Fuchs, A. Forsman, L. Hagberg, M. Larsson, G. Norkrans, G. Reibnegger, E. R. Werner, and H. Wachter. Immune activation and decreased tryptophan in patients with HIV-1 infection. J. Interferon. Res. 10:599 (1990).","journal-title":"J. Interferon. Res."},{"key":"29_CR5","volume-title":"The Haworth Library of the Medical Neurobiology of Somatic Disorders, Vol. 1.","author":"JA Goldstein","year":"1993","unstructured":"J. A. Goldstein. Chronic fatigue syndromes: the limbic hypothesis, in: \u201cThe Haworth Library of the Medical Neurobiology of Somatic Disorders, Vol. 1.\u201d J. A. Goldstein, ed., The Haworth Medical Press, New York (1993)."},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/infdis\/164.5.1023","volume":"164","author":"A Lloyd","year":"1991","unstructured":"A. Lloyd, I. Hickie, A. Brockman, J. Dwyer, and D. Wakefield. Serum and cerebrospinal fluid cytokine levels in patients with chronic fatigue syndrome and control subjects. J. Infect. Dis. 164:1023 (1991).","journal-title":"J. Infect. Dis."},{"key":"29_CR7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.148.1.41","volume":"148","author":"JM Gorman","year":"1991","unstructured":"J. M. Gorman, R. Kertzner, T. Cooper, R. R. Goetz, I. Lagomasino, H. Novacenko, J. B. W. Williams, D. S. W. Yaakov Stern, R. Mayeux, and A. A. Ehrhardt. Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. Am. J. Psychiatry 148:41 (1991).","journal-title":"Am. J. Psychiatry."},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/WNL.41.5.672","volume":"41","author":"CA Meyers","year":"1991","unstructured":"C. A. Meyers, R. S. Scheibe\u2019, and A. D. Forman. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 41:672 (1991).","journal-title":"Neurology"},{"key":"29_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0889-1591(89)90002-0","volume":"3","author":"D Kidron","year":"1989","unstructured":"D. Kidron, D. Saphier, H. Ovadia, J. Weidenfeld, and O. Abramsky. Central administration of immuno\u00admodulatory factors alters neural activity and adrenocortical secretion. Brain Behay. Immun. 3:15 (1989).","journal-title":"Brain Behay. Immun."},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0022-510X(90)90007-A","volume":"100","author":"B Birmanns","year":"1990","unstructured":"B. Birmanns, D. Saphier, and O. Abramsky. a-Interferon modifies cortical EEG activity: dose-depend\u00adency and antagonism by naloxone. J. Neurol. Sci. 100:22 (1990).","journal-title":"J. Neurol. Sci."},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/0006-291X(81)91284-5","volume":"101","author":"JE Blalock","year":"1981","unstructured":"J. E. Blalock, and E. M. Smith. Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity. Biochem. Biophys. Res. Commun. 101:472 (1981).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0024-3205(92)90555-4","volume":"50","author":"RA Menzies","year":"1992","unstructured":"R. A. Menzies, R. Patel, N. R. S. Hall, M. P. O\u2019Grady, and S. E. Rier. Human recombinant interferon alpha inhibits naloxone binding to rat brain membranes. Life Sci. 50:227 (1992).","journal-title":"Life Sci"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00834493","volume":"106","author":"LF Panchenko","year":"1988","unstructured":"L. F. Panchenko, T. N. Aliab\u2019eva, O. B. Petrichenko, V. V. Bumialis, and A. M. Balashov. Spetsificheskoe sviazyvanie mu-i delta-ligandov opiatny miretseptorami golovnogo mozga krys v prisutstvii reaferona. Biull. Eksp. Biol. Med. 106:307 (1988).","journal-title":"Biull. Eksp. Biol. Med."},{"key":"29_CR14","first-page":"20","volume":"4","author":"R D\u2019Urso","year":"1991","unstructured":"R. D\u2019Urso, P. Falaschi, G. Canfalone, E. Carusi, A. Proietti, V. Barnaba, and F. Balsano. Neuroendocrine effects of recombinant \u03b1-interferon administration in humans. Prog. NeuroEndocrinlmmunology 4:20 (1991).","journal-title":"Prog. NeuroEndocrinImmunology"},{"key":"29_CR15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1200\/JCO.1986.4.2.234","volume":"4","author":"JR Quesada","year":"1986","unstructured":"J. R. Quesada, M. Talpaz, A. Rios, R. Kurzrock, and J. U. Gutterman. Clinical toxicology of interferons in cancer patients: a review. J. Clin. Oncol. 4:234 (1986).","journal-title":"J. Clin. Oncol."},{"key":"29_CR16","first-page":"401","volume":"2","author":"RV Smalley","year":"1983","unstructured":"R. V. Smalley, and R. K. Oldham. Interferon as a biological response modifying agent in clinical trials. J. Biol. Resp. Modifiers 2:401 (1983).","journal-title":"J. Biol. Resp. Modifiers."},{"key":"29_CR17","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0028-3908(83)90157-0","volume":"22","author":"N Dafny","year":"1983","unstructured":"N. Dafny. Interferon modifies morphine withdrawal phenomena in rodents. Neuropharmacology 22:647 (1983).","journal-title":"Neuropharmacology"},{"key":"29_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0006-8993(92)91106-O","volume":"590","author":"LS Crnic","year":"1992","unstructured":"L. S. Crnic, and M. A. Segall. Behavioral effects of mouse interferons-\u03b1 and -\u03b3 and human interferon-\u03b1 in mice. Brain Res. 590:277 (1992).","journal-title":"Brain Res"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0014-2999(88)90040-4","volume":"149","author":"H Nakamura","year":"1988","unstructured":"H. Nakamura, K. Nakanishi, A. Kita, and T. Kadokawa. Interleukin-1 induces analgesia in mice by a central action. Eur. J. Pharmacol. 149:49 (1988).","journal-title":"Eur. J. Pharmacol."},{"key":"29_CR20","first-page":"235","volume":"4","author":"N Dafny","year":"1983","unstructured":"N. Dafny. Interferon modifies EEG and EEG-like activity recorded from sensory, motor, and limbic system structures in freely behaving rats. Neurotoxicol. 4:235 (1983).","journal-title":"Neurotoxicol"},{"key":"29_CR21","first-page":"R1096","volume":"261","author":"M Shibata","year":"1992","unstructured":"M. Shibata, and C. M. Blatteis. Differential effects of cytokines on thermosensitive neurons in guinea pig preoptic area slices. Am. J. Physiol. 261:R1096 (1992).","journal-title":"Am. J. Physiol."},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/0304-3940(87)90278-3","volume":"82","author":"T Nakashima","year":"1987","unstructured":"T. Nakashima, T. Maori, K. Kuriyama, and T. Kiyohara. Naloxone blocks the interferon-\u03b1 induced changes induced changes in hypothalamic neuronal activity. Neurosci. Lett. 82:332 (1987).","journal-title":"Neurosci. Lett."},{"key":"29_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0361-9230(91)90230-H","volume":"26","author":"CM Blatteis","year":"1991","unstructured":"C. M. Blatteis, L. Xin, and N. Quan. Neuromodulation of fever: apparent involvement of opioids. Brain Res. Bull. 26:219 (1991).","journal-title":"Brain Res. Bull."},{"key":"29_CR24","volume-title":"A stereotaxic atlas of the rat brain","author":"LJ Pellegrino","year":"1973","unstructured":"L. J. Pellegrino, A. S. Pellegrino, and A. J. Cushman. \u201cA stereotaxic atlas of the rat brain,\u201d Plenum Press, New York (1973)."},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/0028-3908(89)90216-5","volume":"28","author":"D Saphier","year":"1989","unstructured":"D. Saphier, and S. Feldman. Adrenoceptor specificity in the central regulation of adrenocortical secretion. Neuropharmacology 28:1231 (1989).","journal-title":"Neuropharmacology"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1159\/000126369","volume":"57","author":"JE Welch","year":"1993","unstructured":"J. E. Welch, G. E. Farrar, A. J. Dunn, and D. Saphier. Central 5-HT1A receptors inhibit adrenocortical secretion. Neuroendocrinology 57:272 (1993).","journal-title":"Neuroendocrinology"},{"key":"29_CR27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3181\/00379727-170-41391","volume":"170","author":"A Gwosdow-Cohen","year":"1982","unstructured":"A. Gwosdow-Cohen, C. L. Chen, and E. L. Besch. Radioimmunoassay (RIA) of serum corticosterone in rats. Proc. Soc. Exp. Biol. Med. 170:29 (1982).","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"29_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0306-4522(87)90238-7","volume":"20","author":"D Saphier","year":"1987","unstructured":"D. Saphier, and S. Feldman. Effects of septal and hippocampal stimuli on paraventricular nucleus neurones. Neuroscience 20:749 (1987).","journal-title":"Neuroscience"},{"key":"29_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0304-3940(90)90577-V","volume":"114","author":"D Saphier","year":"1990","unstructured":"D. Saphier, and H. Ovadia. Selective facilitation of putative corticotropin-releasing factor-secreting neurones by interleukin-1. Neurosci. Lett. 114:283 (1990).","journal-title":"Neurosci. Lett."},{"key":"29_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0006-8993(88)90157-6","volume":"453","author":"D Saphier","year":"1988","unstructured":"D. Saphier, and S. Feldman. lontophoretic application of glucocorticoids inhibits identified neurones in the rat paraventricular nucleus. Brain Res. 453:183 (1988).","journal-title":"Brain Res"},{"key":"29_CR31","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/0014-2999(93)90588-9","volume":"236","author":"D Saphier","year":"1993","unstructured":"D. Saphier, J. E. Welch, and H. E. Chuluyan. \u03b1-Interferon inhibits adrenocortical secretion via \u00b51-opioid receptors in the rat. Eur. J. Pharmacol. 236:186 (1993).","journal-title":"Eur. J. Pharmacol."},{"key":"29_CR32","doi-asserted-by":"publisher","first-page":"6153","DOI":"10.1093\/nar\/9.22.6153","volume":"9","author":"PK Weck","year":"1981","unstructured":"P. K. Weck, S. Apperson, N. Stebbing, P. W. Gray, D. Leung, H. M. Shepard, and D. V. Goeddel. Antiviral activities of hybrids of two major human leukocyte interferons. Nucleic Acids Res. 9:6153 (1981).","journal-title":"Nucleic Acids Res"},{"key":"29_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/brbi.1994.1004","volume":"8","author":"D Saphier","year":"1994","unstructured":"D. Saphier, S. C. Roerig, C. Ito, W. R. Vlasak, G. E. Farrar, J. E. Broyles, and J. E. Welch. Inhibition of neural and neuroendocrine activity by \u03b1-interferon: neuroendocrine, electrophysiological and biochemi\u00adcal studies in the rat. Brain Behay. Immun. 8:37 (1994).","journal-title":"Brain Behay. Immun."},{"key":"29_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.3014662","volume":"233","author":"HO Besedovsky","year":"1986","unstructured":"H. O. Besedovsky, A. del Rey, E. Sorkin, and C. A. Dinarello. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 233:652 (1986).","journal-title":"Science"},{"key":"29_CR35","doi-asserted-by":"publisher","first-page":"6622","DOI":"10.1073\/pnas.83.17.6622","volume":"83","author":"H Yasui","year":"1986","unstructured":"H. Yasui, K. Takai, R. Yoshida, and O. Hayaishi. Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients. Proc. Natl. Acad. Sci. U.S.A. 83:6622 (1986).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"29_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/ana.410290215","volume":"29","author":"MP Heyes","year":"1991","unstructured":"M. P. Heyes, B. J. Brew, A. Martin, R. W. Price, A. M. Salazar, J. J. Sidtis, J. A. Yergey, M. M. Mouradian, and A. E. Sadler. Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29:202 (1991).","journal-title":"Ann. Neurol."}],"container-title":["Advances in Experimental Medicine and Biology","The Brain Immune Axis and Substance Abuse"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-1951-5_29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T06:10:27Z","timestamp":1619849427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-1951-5_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995]]},"ISBN":["9781461358015","9781461519515"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-1951-5_29","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4615-1951-5","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[1995]]}}}